Pharmaceuticals, Biotechnology and Life Sciences
Sygnature Discovery has added in-house high-throughput screening (HTS) to its range of drug discovery services. This is backed up by its new Leadfinder compound library.
There are many health and safety concerns surrounding seniors living alone. According to the Administration on Aging, approximately 20 percent of men and 36 percent of women over the age of 65 currently live alone, and accidents and close calls are among their biggest risks.
Cytel Inc., the leading global provider of innovative analytical software and consulting services to the life sciences industry, has announced its Complex Innovative Trial Design Symposium and East Training event, which will bring together industry-leading experts to discuss innovative solutions to pressing challenges including rare disease clinical trials, and will also offer delegates an in-depth East software training session.
The UN Political Declaration has for a goal to treat 40 million people for TB disease in the 5-year period 2018-22, and 7 million have already been treated in 2018.
Novartis will work with Microsogt to establish AI innovation lab to empower its associates to use AI across the business, on Novartis Campus (Switzerland), at Novartis Global Service Center in Dublin, and at Microsoft Research Lab (UK) – starting with tackling personalized therapies for macular degeneration; cell & gene therapy; and drug design.
Annie Martin, Global Head of Presicion Medicine, has discussed the future of targeted therapy and genomic profiling, describing how to…
Partnership Combines Life Image’s Global Medical Evidence Network Specializing in Imaging Data with Graticule’s Deep Expertise Applying Advanced Data to…
Author John Hawkins has written a well-researched biography about Termeer’s legacy—how he built a global biotech giant, Genzyme, and mentored…
MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured,…
Sygnature Discovery has developed an AR molecular visualisation prototype, meaning that scientists could soon be rotating virtual molecules in the world around them.